ILANA SAN SOUCI: Open Payments
NPI 1598470189 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,782 in 19 payments from 13 companies in 2025. Trend: 2023 $254 · 2024 $429 · 2025 $1,782
Food & beverage: $1,782
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $367 |
| Teva Pharmaceuticals USA, Inc. | 2 | $253 |
| Alnylam Pharmaceuticals Inc. | 1 | $141 |
| Axsome Therapeutics, Inc. | 2 | $128 |
| Amgen Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $112 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $101 |
| Corcept Therapeutics | 1 | $93 |
Products named: AMVUTTRA, UZEDY, Auvelity, VRAYLAR, BENLYSTA, EVENITY, UBRELVY, EPIDIOLEX.
Industry payments across MI — which companies pay providers there.
